Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial

BACKGROUND: Several meta analyses have concluded n-3 fatty acids, including docosahexaenoic acid (DHA), reduce early preterm birth (EPB, < 34 weeks), however, the amount of DHA required is unclear. We hypothesized that 1000 mg DHA per day would be superior to 200 mg, the amount in most prenatal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlson, Susan E, Gajewski, Byron J, Valentine, Christina J, Kerling, Elizabeth H, Weiner, Carl P, Cackovic, Michael, Buhimschi, Catalin S, Rogers, Lynette K, Sands, Scott A, Brown, Alexandra R, Mudaranthakam, Dinesh Pal, Crawford, Sarah A, DeFranco, Emily A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257993/
https://www.ncbi.nlm.nih.gov/pubmed/34308309
http://dx.doi.org/10.1016/j.eclinm.2021.100905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257993/
https://www.ncbi.nlm.nih.gov/pubmed/34308309
http://dx.doi.org/10.1016/j.eclinm.2021.100905

Ejemplares similares